Biotech

All Articles

Former Seagen chief executive officer reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually marketed to Pfizer in 2014 for a...

Ironwood produces more bid for $1B GI medicine with new subgroup data

.On the heels of a period 3 win that stopped working to thrill capitalists, Ironwood Pharmaceuticals...

Novartis inks $150M deal for autoimmune molecular glue

.Do not cease Monte Rosa Rehabs right now. The Boston-based biotech is enjoying after signing a deal...

Jade carves out director staff with Chinook vets-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings and a...

Septerna goes public along with upsized offering of $288M

.Celebrating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer sounded...

AbbVie brings in Richter richer, paying $25M to form invention pact

.AbbVie has actually gone back to the source of its own antipsychotic powerhouse Vraylar looking for...

GenSight gets into ultimate weeks of cash money path as earnings flow noses out of scope

.GenSight Biologics is actually weeks off of running out of loan. Once again. The biotech just has a...

AZ licenses discarded unusual health condition medicine to Monopar Rehabs

.Monopar Therapeutics is actually recouping a medicine coming from the scrap heap of AstraZeneca's r...

Arcus' brand-new HIF-2a data in kidney cancer mention prospective edge over Merck's Welireg, experts state

.With new records out on Arcus Biosciences' experimental HIF-2a prevention, one group of analysts wo...

Roche wagers up to $1B to increase Dyno genetics therapy distribution pact

.After developing a genetics therapy partnership along with Dyno Therapies in 2020, Roche is actuall...